Clinical Trial

Galvanize Aliya® EX Pulsed Electric Field (PEF) Treat and Resect Study

Study acronym: TARGET
Recruiting
View on ClinicalTrials.gov →
Summary
A prospective, single-arm, non-randomized, single-center, open-label, treat and resect study following patients through surgical resection. The study is designed to evaluate the safety and feasibility of the Aliya EX System for the ablation of pulmonary lesions using pulsed electric field (PEF) energy delivery. The study is intended for adult patients with suspected or confirmed pulmonary malignant lesion(s) ≥1.5 cm to ≤4 cm whom are surgical candidates and have not received treatment for the index tumor in the last two years.
Trial Details
NCT Number NCT07487064
Lead Sponsor Galvanize Therapeutics, Inc.
Conditions Lung Cancer
Enrollment 25 participants
Start Date 2026-03-13
Primary Completion 2027-01-31 (estimated)
Study Completion 2027-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-03-23